Home GCC Bahrain Bahrain approves China’s Sinopharm Covid-19 vaccine The UAE registered the Sinopharm vaccine after finding it had a 86 per cent efficacy rate by Bloomberg December 13, 2020 Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine. “Results from Phase III clinical trials showed an 86 per cent efficacy rate, a 99 per cent seroconversion rate of neutralising antibody and 100 per cent effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement on Sunday. Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorised the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients. Read: Bahrain approves Covid-19 vaccine for frontline workers The UAE registered the Sinopharm vaccine after finding it had a 86 per cent efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy. Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine. Tags Bahrain Phase III Trials Sinopharm UAE Vaccine Volunteers 0 Comments You might also like UAE postpones visa-free travel agreement with Israel until July 1 Covid-19 PCR tests mandatory for inpatient visits to medical facilities in Abu Dhabi Dubai’s Emirates rolls out vaccination programme for its staff Bahrain attracts $885m investment in 2020 despite Covid-19